| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P K Dalal, N Lal, J K Trivedi, P K Seth, A K Agarwal, A Khali. Active platelet 5-ht uptake in depressives treated with impramine and ect. Indian journal of psychiatry. vol 40. issue 1. 2011-07-14. PMID:21494445. |
several studies have reported decreased platelet 5-ht uptake in patients of major depression. |
2011-07-14 |
2023-08-12 |
Not clear |
| P K Dalal, N Lal, J K Trivedi, P K Seth, A K Agarwal, A Khali. Ect and platelet 5ht uptake in major depression. Indian journal of psychiatry. vol 39. issue 4. 2011-07-14. PMID:21584091. |
ect and platelet 5ht uptake in major depression. |
2011-07-14 |
2023-08-12 |
Not clear |
| P K Dalal, N Lal, J K Trivedi, P K Seth, A K Agarwal, A Khali. Ect and platelet 5ht uptake in major depression. Indian journal of psychiatry. vol 39. issue 4. 2011-07-14. PMID:21584091. |
several studies have reported decreased platelet 5-ht uptake in patients of major depression. |
2011-07-14 |
2023-08-12 |
Not clear |
| P K Dalal, N Lal, J K Trivedi, P K Seth, A K Agarwal, A Khali. Ect and platelet 5ht uptake in major depression. Indian journal of psychiatry. vol 39. issue 4. 2011-07-14. PMID:21584091. |
the present work was undertaken with the aim to study the active platelet 5-ht uptake and the effect of ect on it in patients of major depression. |
2011-07-14 |
2023-08-12 |
Not clear |
| Osamu Kano, Ken Ikeda, Derek Cridebring, Takanori Takazawa, Yasuhiro Yoshii, Yasuo Iwasak. Neurobiology of depression and anxiety in Parkinson's disease. Parkinson's disease. vol 2011. 2011-07-14. PMID:21687804. |
the neurochemical changes in pd involving dopamine, norepinephrine, and serotonin might be related to the pathophysiology of depression and anxiety, but this is still not clear. |
2011-07-14 |
2023-08-12 |
Not clear |
| Chantal Moret, Mike Brile. The importance of norepinephrine in depression. Neuropsychiatric disease and treatment. vol 7. issue Suppl 1. 2011-07-14. PMID:21750623. |
although the underlying pathophysiology of depression has not been clearly defined, preclinical and clinical evidence suggest disturbances in serotonin (5-ht), norepinephrine (ne), and dopamine (da) neurotransmission in the central nervous system. |
2011-07-14 |
2023-08-12 |
Not clear |
| Pierre Blier, Mike Brile. The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatric disease and treatment. vol 7. issue Suppl 1. 2011-07-14. PMID:21750624. |
signs and symptoms of depression can be linked to one or more monoaminergic systems, specifically the norepinephrine (ne), the dopamine (da), and the serotonin (5-ht) systems. |
2011-07-14 |
2023-08-12 |
Not clear |
| Pei-Shen Ho, Mei-Chen Shih, Kuo-Hsing Ma, Wen-Sheng Huang, Kellen Kai-Jen Ho, Che-Hung Yen, Ru-Band Lu, San-Yuan Huan. Availability of the serotonin transporter in patients with alcohol dependence. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 12. issue 2. 2011-07-11. PMID:20642399. |
evidence has suggested that the serotonin transporter (sert) plays a role in the pathogenesis of alcohol dependence, anxiety and depression and that polymorphisms of the serotonin-transporter-linked promoter region (5-httlpr) may influence the sert. |
2011-07-11 |
2023-08-12 |
Not clear |
| Ashish Dhir, S K Kulkarn. Nitric oxide and major depression. Nitric oxide : biology and chemistry. vol 24. issue 3. 2011-07-07. PMID:21335097. |
nitric oxide modulates norepinephrine, serotonin, dopamine, glutamate, the major neurotransmitters involved in the neurobiology of major depression. |
2011-07-07 |
2023-08-12 |
Not clear |
| Katja Karg, Margit Burmeister, Kerby Shedden, Srijan Se. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of general psychiatry. vol 68. issue 5. 2011-06-30. PMID:21199959. |
the serotonin transporter promoter variant (5-httlpr), stress, and depression meta-analysis revisited: evidence of genetic moderation. |
2011-06-30 |
2023-08-12 |
Not clear |
| Katja Karg, Margit Burmeister, Kerby Shedden, Srijan Se. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of general psychiatry. vol 68. issue 5. 2011-06-30. PMID:21199959. |
two recent meta-analyses assessed the set of studies exploring the interaction between a serotonin transporter promoter polymorphism (5-httlpr) and stress in the development of depression and concluded that the evidence did not support the presence of the interaction. |
2011-06-30 |
2023-08-12 |
Not clear |
| Jing Fang, Weihong Yan, Guo-Xin Jiang, Wei Li, Qi Chen. Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study. Stroke. vol 42. issue 5. 2011-06-30. PMID:21441157. |
serotonin transporter gene polymorphism in chinese patients with poststroke depression: a case-control study. |
2011-06-30 |
2023-08-12 |
Not clear |
| Maurizio Fava, Kendyl Schaefer, Holly Huang, Amy Wilson, Dan V Iosifescu, David Mischoulon, Thomas C Wesse. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. The Journal of clinical psychiatry. vol 72. issue 4. 2011-06-29. PMID:21208574. |
a post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. |
2011-06-29 |
2023-08-12 |
Not clear |
| Björn Schilström, Asa Konradsson-Geuken, Vladimir Ivanov, Jens Gertow, Kristin Feltmann, Monica M Marcus, Kent Jardemark, Torgny H Svensso. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat. Synapse (New York, N.Y.). vol 65. issue 5. 2011-06-23. PMID:20730799. |
escitalopram, the s-enantiomer of citalopram, possesses superior efficacy compared to other selective serotonin reuptake inhibitors (ssris) in the treatment of major depression. |
2011-06-23 |
2023-08-12 |
rat |
| Ari Illi, Outi Poutanen, Eija Setälä-Soikkeli, Olli Kampman, Merja Viikki, Heini Huhtala, Nina Mononen, Susann Haraldsson, Pasi A Koivisto, Esa Leinonen, Terho Lehtimäk. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD? European archives of psychiatry and clinical neuroscience. vol 261. issue 2. 2011-06-21. PMID:20640435. |
the role of a functional polymorphism in the transcriptional control region of serotonin transporter gene (5-httlpr, sertpr) has been studied intensively in major depression and in the response to selective serotonin inhibitors (ssris) in major depression. |
2011-06-21 |
2023-08-12 |
Not clear |
| Igor Branch. The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology. vol 36. issue 3. 2011-06-21. PMID:20875703. |
the double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. |
2011-06-21 |
2023-08-12 |
Not clear |
| Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelle. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. vol 36. issue 3. 2011-06-21. PMID:21041030. |
inflammation-associated depression: from serotonin to kynurenine. |
2011-06-21 |
2023-08-12 |
Not clear |
| Thomas Mueggler, Florence Razoux, Holger Russig, Anna Buehler, Tamara B Franklin, Christof Baltes, Isabelle M Mansuy, Markus Rudi. Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 21. issue 4. 2011-06-15. PMID:20656461. |
the method opens novel perspectives for investigating 5-ht(1a) receptor functions in mouse models of human pathologies resulting from a dysfunction of the 5-ht(1a) receptor or the serotonergic system, including depression and anxiety. |
2011-06-15 |
2023-08-12 |
mouse |
| Judith R Homberg, Klaus-Peter Lesc. Looking on the bright side of serotonin transporter gene variation. Biological psychiatry. vol 69. issue 6. 2011-06-10. PMID:21047622. |
converging evidence indicates an association of the short (s), low-expressing variant of the repeat length polymorphism, serotonin transporter-linked polymorphic region (5-httlpr), in the human serotonin transporter gene (5-htt, sert, slc6a4) with anxiety-related traits and increased risk for depression in interaction with psychosocial adversity across the life span. |
2011-06-10 |
2023-08-12 |
human |
| Ayelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, Moshe Rehavi, Julia C Stingl, David Gurwit. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker. Pharmacogenomics. vol 12. issue 2. 2011-06-08. PMID:21332311. |
selective serotonin reuptake inhibitors (ssris) are the most commonly used class of antidepressants for treating major depression. |
2011-06-08 |
2023-08-12 |
human |